Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


Neuronetics to Present at The JMP Securities Life Sciences Conference


GlobeNewswire Inc | Jun 3, 2021 08:00AM EDT

June 03, 2021

MALVERN, Pa., June 03, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc.(NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that Keith Sullivan, President and Chief Executive Officer, and Steve Furlong, Senior Vice President, Chief Financial Officer, and Treasurer, will participate at The JMP Securities Life Sciences Conference. The Company is scheduled to present on Thursday, June 17, 2021 at 10:00am ET.

A live audio webcast of the presentation will be available online at the investor relations page of the Companys website at ir.neuronetics.com. A replay of the webcast will be archived on the website for approximately 90 days.

AboutNeuronetics

Neuronetics, Inc. is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The system is cleared by the United States Food and Drug Administration, or FDA, for the treatment of major depressive disorder in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode. NeuroStar is also available in other parts of the world, including Japan, where it is listed under Japans national health insurance. Additional information can be foundat www.neuronetics.com.

Investor Contact:

Mike Vallie or Mark KlausnerWestwicke Partners443-213-0499ir@neuronetics.com

Media Contact:

Chelsey MankoVault Communications610-455-2778cmanko@vaultcommunications.com







Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC